Katsunori Imai Selected Research

Katsunori Imai Research Topics

Disease

77	Neoplasms (Cancer) 11/2022 - 09/2007
54	Hepatocellular Carcinoma (Hepatoma) 11/2022 - 09/2007
37	Neoplasm Metastasis (Metastasis) 04/2022 - 11/2012
13	Cholangiocarcinoma 10/2021 - 05/2010
12	Pancreatic Neoplasms (Pancreatic Cancer) 06/2022 - 10/2008
9	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 10/2008
7	Inflammation (Inflammations) 07/2022 - 12/2017
7	Lymphatic Metastasis 06/2022 - 12/2017
7	Liver Diseases (Liver Disease) 08/2021 - 12/2012
6	Adenocarcinoma 01/2022 - 01/2018
5	Fibrosis (Cirrhosis) 01/2022 - 11/2014
4	Colonic Neoplasms (Colon Cancer) 04/2022 - 11/2012
4	Ascites 06/2021 - 10/2012
3	Carcinogenesis 12/2021 - 12/2017
3	Klatskin Tumor 09/2020 - 12/2016
3	Disease Progression 02/2020 - 01/2016
3	Thrombosis (Thrombus) 01/2019 - 09/2007
3	Lung Neoplasms (Lung Cancer) 04/2011 - 12/2008
2	Rectal Neoplasms (Rectal Cancer) 04/2022 - 06/2014
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 05/2014
2	Chronic Hepatitis C 04/2021 - 04/2020
2	Liver Abscess 08/2020 - 01/2018
2	False Aneurysm (Pseudoaneurysm) 08/2020 - 05/2017
2	Hemorrhage 08/2020 - 05/2017
2	Residual Neoplasm 01/2020 - 01/2018
2	Hepatic Insufficiency 09/2019 - 01/2019
2	Stomach Neoplasms (Stomach Cancer) 01/2018 - 12/2016
2	Liver Neoplasms (Liver Cancer) 01/2018 - 02/2016
2	Dysbiosis 12/2017 - 01/2017
2	Carcinoma (Carcinomatosis) 03/2017 - 08/2012
1	Rectal Diseases (Rectal Disease) 04/2022
1	Colonic Diseases 04/2022
1	Surgical Wound Infection 02/2022
1	Wounds and Injuries (Trauma) 02/2022

Drug/Important Bio-Agent (IBA)

15	AntigensIBA 06/2022 - 10/2008
10	Tumor Biomarkers (Tumor Markers)IBA 03/2021 - 08/2012
9	CarbohydratesIBA 01/2022 - 12/2015
8	Carcinoembryonic AntigenIBA 03/2021 - 10/2014
7	AlbuminsIBA 01/2022 - 01/2018
6	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2018
5	Proteins (Proteins, Gene)FDA Link 11/2021 - 09/2010
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2020 - 03/2013
5	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 03/2013
5	Fetal Proteins (Fetoprotein)IBA 02/2019 - 01/2018
5	Prothrombin (Factor II)IBA 01/2019 - 09/2017
5	Peptides (Polypeptides)IBA 04/2011 - 10/2008
5	Complementary DNA (cDNA)IBA 04/2011 - 10/2008
4	Messenger RNA (mRNA)IBA 06/2022 - 05/2010
4	Biological ProductsIBA 04/2022 - 01/2020
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2021 - 05/2018
4	Gemcitabine FDA Link 02/2020 - 08/2012
4	DNA (Deoxyribonucleic Acid)IBA 06/2019 - 01/2017
3	Codon (Codons)IBA 04/2022 - 11/2019
3	Human Serum Albumin FDA LinkGeneric 10/2021 - 05/2014
3	lentil lectinIBA 04/2021 - 01/2019
3	Histones (Histone)IBA 01/2021 - 12/2013
3	C-Reactive ProteinIBA 12/2020 - 01/2018
3	EnzymesIBA 05/2020 - 01/2008
3	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 12/2016
3	EpitopesIBA 04/2011 - 12/2008
3	HLA-A2 Antigen (HLA A2 Antigen)IBA 01/2011 - 10/2008
2	Capsules (Microcapsules)IBA 05/2022 - 10/2021
2	BilirubinIBA 01/2022 - 08/2014
2	Oxygen (Dioxygen)IBA 08/2021 - 12/2016
2	Bevacizumab (Avastin)FDA Link 06/2020 - 12/2015
2	Serum AlbuminIBA 02/2020 - 12/2014
2	Small Interfering RNA (siRNA)IBA 01/2020 - 09/2015
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 01/2014
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 11/2019 - 09/2014
2	acarboxyprothrombin (PIVKA)IBA 02/2019 - 05/2018
2	ProstaglandinsIBA 01/2019 - 02/2018
2	15-hydroxyprostaglandin dehydrogenaseIBA 01/2019 - 02/2018
2	Enhancer of Zeste Homolog 2 ProteinIBA 10/2018 - 12/2013
2	Sorafenib (BAY 43-9006)FDA Link 04/2018 - 12/2016
2	Bile Acids and Salts (Bile Acids)IBA 12/2017 - 12/2012
2	Indicators and Reagents (Reagents)IBA 06/2017 - 11/2014
2	Pharmaceutical PreparationsIBA 12/2016 - 01/2014
2	Leucovorin (Folinic Acid)FDA Link 12/2015 - 01/2014
2	Cadherins (E-Cadherin)IBA 09/2015 - 10/2008
2	Therapeutic UsesIBA 10/2014 - 09/2007
2	HLA-A24 AntigenIBA 04/2011 - 09/2010
1	Dihydrotachysterol (AT 10)IBA 04/2022
1	PlasticsIBA 02/2022

Therapy/Procedure

56	Hepatectomy 11/2022 - 06/2012
24	Drug Therapy (Chemotherapy) 06/2022 - 09/2007
22	Therapeutics 01/2022 - 09/2007
15	Radiofrequency Ablation 05/2021 - 05/2014
9	Immunotherapy 01/2019 - 10/2008
8	Pancreaticoduodenectomy 01/2022 - 05/2017
5	Adjuvant Chemotherapy 06/2022 - 03/2013
4	Pancreatectomy 01/2022 - 01/2017
3	Erythrocyte Transfusion 01/2022 - 01/2018
3	Punctures 07/2020 - 12/2012
3	Lymph Node Excision (Lymph Node Dissection) 04/2019 - 01/2017
2	Catheters 08/2020 - 06/2012
2	Operative Surgical Procedures 07/2020 - 11/2016
2	Conservative Treatment 01/2020 - 10/2012
2	Ligation 09/2019 - 08/2018
1	Activities of Daily Living (ADL) 11/2022
1	Perioperative Period 02/2022